MorphoSys Chooses Incyte As Its Global Tafasitamab Partner

Analysts Cheer MorphoSys’s Choice Of Commercial Ally And Deal’s Terms

 
• By Sten Stovall
  
Partnership
Duo Will Jointly Develop MorphoSys’s CD19 Targeting Antibody • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip